Baillie Gifford & Co
HALO icon

Baillie Gifford & Co’s Halozyme HALO Stock Holding History

Baillie Gifford & Co’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-763
Closed -$43.4K – 466
2022
Q4 		$43.4K Hold
763
– – ﹤0.01% 299
2022
Q3 		$30K Sell
763
-52
-6% -$2.3K ﹤0.01% 308
2022
Q2 		$36K Buy
815
+36
+5% +$1.56K ﹤0.01% 303
2022
Q1 		$31K Hold
779
– – ﹤0.01% 315
2021
Q4 		$31K Sell
779
-101
-11% -$3.77K ﹤0.01% 322
2021
Q3 		$36K Sell
880
-82
-9% -$3.43K ﹤0.01% 304
2021
Q2 		$44K Sell
962
-44
-4% -$1.95K ﹤0.01% 294
2021
Q1 		$42K Buy
1,006
+52
+5% +$2.37K ﹤0.01% 288
2020
Q4 		$41K Buy
+954
New +$34.3K ﹤0.01% 277

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Baillie Gifford & Co's HALO Position: Q1 2023 in Review

Baillie Gifford & Co sold out of Halozyme (HALO) in Q1 2023, closing a stake of 763 shares — an estimated $43.4K sold.

Baillie Gifford & Co first reported a position in HALO in Q4 2020 and held it in 9 quarters. The position peaked at $44K in Q2 2021. 386 funds tracked by Wall St. Rank hold HALO as of Q1 2023.

  • Baillie Gifford & Co reported no remaining Halozyme position as of Q1 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 763 Halozyme shares in Q1 2023, an estimated $43.4K.
  • Baillie Gifford & Co first reported a position in Halozyme in Q4 2020 and held it in 9 quarters.
  • Baillie Gifford & Co's Halozyme position peaked at $44K in Q2 2021.
  • 386 funds tracked by Wall St. Rank held Halozyme as of Q1 2023.

Based on Baillie Gifford & Co's 13F filing for Q1 2023, filed 3 May 2023.